Synthaverse (FRA:6NQ) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6NQ Synthaverse SA FRA:6NQ
41 GF Score
Price €0.64
GF Value €0.69
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Synthaverse Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:6NQ vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Synthaverse's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthaverse Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthaverse's Short Interest distribution charts can be found below:

* The bar in red indicates where Synthaverse's Short Interest falls into.


FRA:6NQ
41GF Score
Synthaverse SA FRA:6NQ
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Synthaverse (FRA:6NQ) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of €0.64 is trading 8% below its estimated GF Value™ of €0.69. GuruFocus considers Synthaverse to be Fairly Valued.

Key valuation signals for FRA:6NQ:

  • Short Interest:
  • GF Value™: €0.69 vs. price of €0.64 (8% below fair value)
  • GF Score™: 41/100 with 8 warning signs

No single metric tells the full story. See the FRA:6NQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synthaverse Business Description

Other Exchanges SVE:Poland
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
41GF Score

Get the complete analysis for FRA:6NQ

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.64
Price
€0.69
GF Value